Vijayshree Yadav, M.D., M.C.R., FANA, FAAN
- Professor of Neurology, School of Medicine
- Director, OHSU Multiple Sclerosis Center, School of Medicine
- Director, MS and Neuroimmunology Fellowship, OHSU Multiple Sclerosis Center, School of Medicine
- Anne Middleton Foster Endowed Professorship in Neurology
Biography
Dr. Yadav is a board certified neurologist who received her medical degree in 1995 from SN Medical College in Agra, India. She completed her fellowship in neuroimmunology and multiple sclerosis at Oregon Health & Science University and Portland VA Medical Center in 2004. In 2004, she joined the OHSU Multiple Sclerosis Center and is a Professor in the Department of Neurology. She received her masters in clinical research in 2008 and in 2010 was appointed clinical medical director of the OHSU Multiple Sclerosis Center. She was appointed Director of the Multiple Sclerosis and Neuroimmunology Fellowship program in 2017. She was appointed as the Director of the OHSU Multiple Sclerosis Center in 2020.
Dr. Yadav's research interests include complementary and alternative treatment options for multiple sclerosis including dietary and life style changes as well as supplements such as lipoic acid and MitoQ. She has published several peer reviewed journal articles and presented her research at national and international meetings.
Education and training
-
Degrees
- M.D., 1995, SN Medical College
- M.C.R., 2008, OHSU
-
Residency
- Neurology, Oregon Health & Science University, Portland, OR, 2001
-
Fellowship
- Neuroimmunology and multiple sclerosis, Oregon Health & Science University and Portland VA Medical Center, 2004
-
Certifications
- American Board of Psychiatry and Neurology
Memberships and associations:
- American Academy of Neurology
- American Neurological Association
- Consortium of MS Centers
Areas of interest
- wellness in MS
- dietary factors and its role in MS
- anti oxidants in MS
- vascular risk factors in MS
- provider education
- patient education
Honors and awards
- Fellow of American Academy of Neurology
- Fellow of American Neurological Association
Publications
Elsevier pure profilePublications
Clinical and radiographic features of a cohort of adult and pediatric subjects in the Pacific Northwest with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)
Multiple sclerosis and related disordersA low-fat diet improves fatigue in multiple sclerosis
Multiple Sclerosis JournalRisk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS)
The Lancet NeurologyVascular disease risk factors in multiple sclerosis
Multiple sclerosis and related disordersDemyelinating Disease after Exposure to Tumor Necrosis Factor α Inhibitors
Journal of Clinical RheumatologyA cross-sectional survey of cannabis use by people with MS in Oregon and Southwest Washington
Multiple sclerosis and related disordersEffects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study
NeurologyRituximab for treatment of refractory multiple sclerosis relapses during pregnancy
Multiple Sclerosis JournalCross-sectional survey of complementary and alternative medicine used in Oregon and Southwest Washington to treat multiple sclerosis
Multiple sclerosis and related disordersSpinal adhesive arachnoiditis mimicking sarcoid myelitis with nodular dural enhancement
Multiple sclerosis and related disordersOral lipoic acid as a treatment for acute optic neuritis
Multiple Sclerosis Journal - Experimental, Translational and ClinicalEffect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND)
The Lancet NeurologyLipoic Acid Stimulates cAMP Production in Healthy Control and Secondary Progressive MS Subjects
Molecular NeurobiologyPhase 2 trial of ibudilast in progressive multiple sclerosis
New England Journal of MedicineLipoic acid in secondary progressive MS
Neurology: Neuroimmunology and NeuroInflammationMIF and D-DT are potential disease severity modifiers in male MS subjects
Proceedings of the National Academy of Sciences of the United States of AmericaDesign, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis
Contemporary Clinical TrialsLow-fat, plant-based diet in multiple sclerosis
Multiple sclerosis and related disordersThe contemporary spectrum of multiple sclerosis misdiagnosis
NeurologyComplementary and alternative medical therapies in multiple sclerosis - The American Academy of Neurology Guidelines
Clinical therapeutics